Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2020Antimicrobial Agents and ChemotherapyOpen Access

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCaleb P SkipperMAMucunguzi AtukundaASAnna Stadelman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Skipper et al. (2020) studied this question.

synapsesocial.com/papers/6a9a334e1aede4d0e945bd38https://doi.org/10.1128/aac.00838-20
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis2019 · 67 citations
  2. 2Efficacy of Orally Delivered Cochleates Containing Amphotericin B in a Murine Model of Aspergillosis2002 · 112 citations
  3. 3Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis2014 · 503 citations
  4. 4Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans2002 · 321 citations